Cardinal Health profits

The chief financial officer of Cardinal Heath Inc. Jeff Henderson, says the health care products and services company expects revenue to grow “at about market” as the company works to improve its drug distribution and clinical and medical products units.

Over time, Henderson said the company plans to have as much as 40 percent of its profits come from its other division, clinical and medical products. He said there is room to improve overseas sales for the Alaris business, which distributes intravenous drug delivery systems and monitoring products.

Henderson said the clinical and medical products business is focused on improving health care safety. He pointed to growing concerns about hospital-borne infections, which have received increased media attention because of outbreaks of drug-resistant staph infections.

Click here for the full story.

 

Other stories